Abstract GS1-09: Inhibition of GPX4 induces preferential death of p53-mutant triple-negative...

Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles

J Zhang, K Zhou, J Lin, X Yao, D Ju, X Zeng, Z Pang… - Biomaterials, 2023 - Elsevier
Triple-negative breast cancer (TNBC) causes great suffering to patients because of its
heterogeneity, poor prognosis, and chemotherapy resistance. Ferroptosis is characterized …
被引用次数：13 相关文章 所有 3 个版本

Ferroptosis as a promising targeted therapy for triple negative breast cancer

K Mokhtarpour, S Razi, N Rezaei - Breast Cancer Research and …, 2024 - Springer
Purpose Triple negative breast cancer (TNBC) is a challenging subtype characterized by the
absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal …
被引用次数：4 相关文章 所有 2 个版本

PPA1, TRIM68 and FBXO46: Potential Therapeutic Targets for Triple Negative Breast Cancer

F Haider, N Syed, SAZ Jaffari, B Syed… - Current Protein & …, 2025 - benthamdirect.com
Background Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer
with a high recurrence rate. A new therapeutic intervention is urgently needed to combat this …
相关文章 所有 2 个版本